(Q54104969)

24 May 2018

title

Bacterial infection in the pathogenesis of variceal bleeding. (English)

1 reference

24 May 2018

author name string

J Goulis

series ordinal

1

1 reference

24 May 2018

D Patch

series ordinal

2

1 reference

24 May 2018

A K Burroughs

series ordinal

3

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

24 May 2018

published in

The Lancet

1 reference

24 May 2018

volume

353

1 reference

24 May 2018

issue

9147

1 reference

24 May 2018

page(s)

139-142

1 reference

24 May 2018

Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Why portal hypertensive varices bleed and bleed: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Prognostic significance of bacterial infection in bleeding cirrhotic patients: A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

The endothelin system. A new target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Molecular characterization of endothelin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Inhibition of platelet aggregation by abnormal high density lipoprotein particles in plasma from patients with hepatic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Pharmacodynamic profile of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endotoxin alters arachidonate metabolism in pulmonary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Hyperdynamic circulation in cirrhosis: a role for nitric oxide?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Portal hypertension and variceal bleeding: an AASLD single topic symposium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2906020-6

7 January 2021

10.1016/S0140-6736(98)06020-6

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018